rfhg_124619.1

Basic information about the TSS

---

TSS ID: rfhg_124619.1 Species: human Chr: chr10		Start: 32992436 End: 32992455 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000534049.5:-8 GeneID: 3688 HGNC/MGI_ID: HGNC:6153 UniProt_ID: E9PLR6 Nearer transcript ids and distances:

Gene_name: integrin subunit beta 1 Gene_symbol: ITGB1 Gene_synonyms: CD29 GPIIA Gene_source: HGNC:6153

TATA-Box annotation

---

Distance to TSS:	-34215
Nearest PromoterID:	NM_002211
Entrez ID:	3688
Nearest Unigene:	Hs.643813
Nearest Refseq:	NM_002211
Nearest Ensembl:	ENSG00000150093
Gene Name:	integrin subunit beta 1
Gene Alias:	CD29|FNRB|GPIIA|MDF2|MSK12|VLA-BETA|VLAB
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ITGB1 p2@ITGB1 p3@ITGB1 p4@ITGB1 p5@ITGB1 p8@ITGB1
Sample		p1@ITGB1	p2@ITGB1	p3@ITGB1	p4@ITGB1	p5@ITGB1	p8@ITGB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	38.18	1.36	0.58	0.19	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.04	2.02	0.20	0.61	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.23	1.54	0.77	0.39	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.82	2.70	0.42	0.00	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.70	2.70	1.57	0.90	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.43	2.13	0.19	0.19	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	50.55	1.96	1.96	0.44	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.40	0.24	0.73	0.00	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.64	2.14	0.43	0.43	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	26.66	5.80	1.74	1.16	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.19	4.45	0.81	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	23.99	2.85	0.00	0.81	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	280.15	4.35	1.93	0.48	2.10	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	259.05	6.16	2.10	0.60	2.41	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	285.20	4.39	2.63	0.22	2.20	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	228.35	4.02	1.26	0.50	3.52	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	204.43	5.46	2.62	0.87	1.53	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	210.49	5.06	1.69	0.00	3.80	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	192.47	2.13	3.20	1.07	2.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	271.40	6.92	3.61	1.96	1.96	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	279.47	7.22	2.41	0.53	3.34	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	281.03	5.35	2.59	0.52	0.86	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	241.84	5.95	2.84	1.42	2.46	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	229.81	8.74	2.91	0.97	1.94	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	233.74	8.51	2.06	0.77	1.81	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	207.95	9.50	2.53	1.58	2.22	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	226.93	6.04	0.55	0.55	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	327.93	7.78	4.95	0.24	3.30	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	276.04	6.78	2.58	1.29	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	280.13	7.60	2.17	0.90	2.35	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	256.45	5.86	3.14	1.67	1.67	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	246.18	6.84	1.17	0.98	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	259.99	6.96	2.74	1.48	2.74	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	331.53	9.90	3.63	0.82	1.48	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	270.95	8.23	2.62	1.12	2.43	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	266.16	7.47	3.64	0.96	2.49	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	267.94	5.93	1.84	0.82	2.25	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	230.70	6.25	1.21	1.81	1.41	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	306.84	8.64	2.97	2.16	1.35	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	292.16	8.16	2.88	1.20	1.92	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	238.32	6.59	1.88	0.47	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	305.23	8.20	1.76	1.32	1.32	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	301.37	6.33	2.53	0.63	2.74	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	286.02	6.29	3.67	1.92	2.10	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	343.52	6.42	3.21	1.20	2.21	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	321.05	8.84	3.95	2.09	3.72	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	267.26	7.92	3.36	1.92	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	355.28	8.64	3.87	0.89	1.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	286.29	12.45	4.07	1.44	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	331.60	7.68	3.64	1.42	2.43	1.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	328.95	11.68	1.64	1.64	4.30	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	318.00	14.45	1.78	3.11	4.89	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1791.00	41.98	13.99	41.98	223.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	220.37	12.07	2.13	0.71	2.48	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	240.92	9.61	0.66	1.99	2.98	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	795.31	16.78	2.52	3.36	31.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	521.24	8.27	2.30	2.76	3.21	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	256.05	14.26	3.57	2.92	2.92	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	217.43	18.63	0.32	1.61	1.93	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	566.42	10.37	2.20	1.89	2.51	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	260.16	8.46	1.41	4.94	2.12	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	266.37	14.02	3.36	5.61	2.80	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	1203.77	22.29	1.59	11.94	46.97	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	677.84	21.07	4.08	7.47	4.42	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	360.01	20.79	1.62	6.17	1.30	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	403.26	27.69	2.84	8.16	7.10	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	3216.62	48.49	96.98	32.33	145.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	3466.99	78.97	31.59	7.90	118.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	394.40	22.43	1.46	13.65	6.34	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	468.60	27.77	3.47	10.41	4.46	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	420.80	24.39	2.81	9.85	2.81	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	692.18	19.87	1.99	8.94	3.64	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	441.74	22.27	4.33	6.50	2.47	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	513.96	23.85	2.75	10.09	4.59	2.45
Adipocyte - breast, donor1	11376-118A8	669.81	17.11	7.29	3.33	4.43	0.63
Adipocyte - breast, donor2	11327-117E4	579.46	13.64	6.26	2.73	11.55	1.28
Adipocyte - omental, donor1	11473-119C6	801.28	26.85	8.27	5.34	5.22	2.04
Adipocyte - omental, donor2	11474-119C7	622.66	9.72	2.24	2.99	8.97	0.75
Adipocyte - omental, donor3	11475-119C8	613.24	17.08	3.35	3.35	4.02	0.33
Adipocyte - perirenal, donor1	11476-119C9	523.15	8.93	3.19	2.55	7.02	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	152.83	2.20	2.20	2.20	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	189.23	10.84	2.71	0.45	1.35	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	87.93	2.09	1.04	0.17	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	626.03	19.75	3.32	1.17	2.35	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	526.08	16.99	3.86	2.32	3.09	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	523.81	10.31	3.07	2.79	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	468.49	12.34	5.29	0.00	3.53	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	527.16	8.61	4.91	0.24	1.13	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	315.33	3.23	3.87	0.32	3.87	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	235.67	8.53	2.13	0.53	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	234.82	3.34	1.11	0.00	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	261.18	7.49	2.50	0.42	2.08	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	221.28	4.52	3.27	0.50	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	224.82	6.87	3.60	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	238.40	10.66	4.26	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	88.40	8.18	2.87	4.20	0.22	2.65
Alveolar Epithelial Cells, donor2	11590-120G6	24.74	1.43	0.00	0.00	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	37.14	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	149.14	5.76	3.42	0.90	0.54	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	113.61	11.71	2.47	4.11	1.44	1.64
Anulus Pulposus Cell, donor1	11248-116E6	380.24	9.96	6.64	1.37	1.26	0.34
Anulus Pulposus Cell, donor2	11463-119B5	452.59	8.82	3.43	1.96	2.94	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	791.66	23.81	5.84	17.52	11.68	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	872.19	19.97	7.38	17.37	9.55	5.21
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	603.55	32.10	6.42	23.54	25.68	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	800.81	18.83	7.47	17.04	7.77	2.39
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	930.78	13.91	6.32	8.85	13.91	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	487.13	20.46	6.60	19.80	9.90	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	731.32	18.52	5.52	12.67	5.20	3.25
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	771.37	20.87	3.88	13.11	5.34	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	546.96	27.91	7.72	15.44	10.69	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	833.12	18.83	7.53	10.55	8.29	5.27
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	806.22	23.22	5.08	12.34	5.08	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	383.66	16.30	6.27	5.02	10.03	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	894.52	45.47	11.70	22.73	3.46	7.08
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	857.10	20.47	12.28	10.92	8.19	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	663.18	40.41	6.33	24.88	5.58	5.73
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	795.64	17.68	8.57	16.07	1.61	6.97
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	867.21	25.51	7.94	17.19	6.61	5.67
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	657.79	28.33	11.23	16.57	12.30	6.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	796.94	24.39	4.88	7.80	7.80	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	885.36	25.04	8.62	12.44	6.30	6.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	493.50	25.22	10.81	8.41	9.61	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	792.99	31.86	3.54	3.54	14.16	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	870.00	24.70	10.98	15.61	8.58	5.15
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	503.40	25.17	0.00	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	810.66	27.18	4.85	11.16	11.65	4.37
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	973.67	26.94	9.87	17.83	6.83	7.21
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	580.24	13.33	4.85	12.11	8.48	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	786.08	18.24	7.98	10.83	10.26	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	874.98	30.57	7.48	11.97	4.70	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	546.12	22.71	5.42	14.97	8.52	4.39
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	754.48	27.68	4.69	12.20	2.82	4.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	773.33	21.22	8.04	14.15	12.86	5.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	450.90	20.69	7.85	12.84	6.42	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	620.63	27.49	6.43	9.36	8.19	4.09
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	799.65	25.59	6.92	13.85	8.13	7.23
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	576.18	21.38	5.94	17.82	7.13	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	809.12	13.73	5.09	12.71	6.10	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	931.14	28.78	9.93	19.36	15.54	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	490.50	23.51	9.53	13.98	3.81	4.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	726.27	18.99	5.61	12.51	5.61	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	848.44	22.02	8.04	18.42	6.56	4.87
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	464.26	25.81	6.67	14.50	5.51	4.64
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	878.60	28.34	6.61	18.89	6.61	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	794.73	23.73	6.78	12.38	7.12	5.26
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	428.53	34.75	4.63	9.27	11.58	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	874.60	21.13	10.56	12.68	8.45	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	803.40	23.59	9.22	15.44	5.79	4.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	534.88	24.67	7.22	9.02	4.81	4.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	720.23	18.95	4.37	8.02	11.66	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	935.16	25.06	8.28	14.94	6.21	5.98
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	657.98	45.91	7.65	25.50	38.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	768.54	51.86	12.20	29.49	8.14	9.92
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	958.29	25.19	10.94	18.58	7.84	6.61
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	622.40	29.07	7.65	16.52	11.63	7.34
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	945.99	24.86	5.26	10.52	11.95	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	884.52	25.06	6.65	14.86	9.31	5.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	491.31	32.04	9.15	22.89	10.68	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	725.59	27.14	7.75	9.42	7.75	3.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	862.96	25.42	10.33	19.33	8.47	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	581.15	21.81	8.72	9.81	7.27	5.09
Astrocyte - cerebellum, donor1	11500-119F6	62.02	3.56	0.61	0.74	0.61	0.00
Astrocyte - cerebellum, donor2	11580-120F5	60.76	2.74	1.03	0.34	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	23.70	1.89	0.21	0.00	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	283.75	2.09	4.18	0.35	0.70	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	325.65	5.50	6.63	0.49	3.07	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	265.95	7.16	5.97	3.58	1.04	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.93	0.00	0.11	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.01	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.53	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	49.17	0.52	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	278.53	1.80	1.80	0.00	0.72	0.72
Basophils, donor3	12243-129H2	105.69	0.73	0.59	0.00	0.00	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	37.08	3.67	1.29	0.43	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	16.00	4.11	0.46	0.91	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	114.78	0.00	0.00	0.00	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	165.70	13.81	0.63	4.39	0.00	6.28
Bronchial Epithelial Cell, donor5	11457-119A8	118.95	9.36	0.62	2.08	0.21	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	114.22	19.34	1.84	4.84	0.46	3.45
Bronchial Epithelial Cell, donor7	11769-123I5	268.12	6.66	2.52	0.90	2.52	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	80.49	0.21	0.82	0.00	0.21	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	49.84	0.23	0.93	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	41.57	0.32	0.32	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	139.20	1.13	0.56	0.00	0.56	1.69
CD14+ Monocytes, donor2	11305-117B9	128.62	0.74	0.00	0.00	1.30	0.37
CD14+ Monocytes, donor3	11381-118B4	89.57	0.66	0.00	0.00	0.66	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	171.24	4.25	0.85	0.57	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	185.37	2.65	1.14	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	196.92	3.29	0.99	0.00	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	168.83	3.04	1.01	0.29	1.16	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	169.58	2.41	0.91	1.21	1.21	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	159.90	2.37	0.47	0.00	1.66	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	146.14	3.52	2.01	0.50	1.51	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	183.00	2.21	1.10	1.10	2.21	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	180.99	2.23	1.24	0.50	1.49	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	118.85	3.52	1.17	0.20	1.37	1.17
CD14+ monocytes - treated with BCG, donor2	11870-125B7	121.43	1.96	1.42	0.00	0.89	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	136.89	2.61	0.65	0.00	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	165.76	6.32	0.94	0.70	1.64	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	193.26	2.64	2.64	1.06	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	147.54	3.33	0.00	0.00	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	172.85	3.42	1.93	0.30	1.19	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	216.71	2.20	0.60	1.40	1.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	239.43	2.08	1.46	0.00	1.46	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	245.71	8.24	2.75	1.60	3.20	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	272.12	4.30	1.13	2.26	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	189.42	2.18	1.31	0.00	2.62	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	100.06	1.34	0.27	0.00	0.81	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	119.16	1.05	1.22	0.35	1.05	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	103.52	1.26	1.26	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	222.84	3.67	2.57	0.92	5.33	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	233.90	2.47	2.11	0.70	2.82	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	216.29	2.63	1.75	0.00	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	129.04	4.53	2.27	0.35	3.14	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	119.68	3.35	1.12	1.12	3.72	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	151.32	3.23	1.29	0.00	1.29	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	136.77	2.87	1.23	0.82	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	193.55	3.01	2.32	0.93	0.23	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	158.22	1.16	0.93	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	87.84	0.22	0.00	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	82.70	0.46	0.00	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	62.39	0.00	0.22	0.00	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	86.43	0.62	0.47	0.00	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	74.57	0.52	0.52	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	119.29	0.89	0.45	0.00	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	78.85	0.26	0.77	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	99.02	0.44	0.66	0.00	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	105.06	0.42	0.00	0.00	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	172.75	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	151.87	2.03	4.07	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	131.52	0.00	0.00	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	202.02	4.80	2.13	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	221.40	3.22	0.54	0.00	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	146.71	0.70	2.11	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	155.30	3.14	0.78	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	168.74	1.32	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	57.53	1.64	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	60.21	1.45	0.00	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	69.67	3.03	1.01	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	230.72	0.00	0.40	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	140.62	0.80	0.00	0.00	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	46.19	0.00	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	84.27	1.12	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	66.13	3.38	1.88	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	61.56	2.03	1.58	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	151.75	0.00	2.14	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	188.00	3.06	0.61	0.00	4.29	0.61
CD4+ T Cells, donor3	11382-118B5	254.97	1.22	0.00	0.61	3.35	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	19.65	0.00	0.00	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	18.64	0.22	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.83	0.29	0.00	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	80.60	0.00	0.00	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	104.65	0.70	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	59.33	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	127.90	1.16	0.14	0.14	0.58	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	57.96	1.02	0.17	0.34	0.51	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	61.58	1.29	0.32	0.00	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	237.15	1.34	2.24	0.45	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	316.90	1.75	0.70	0.35	1.75	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	488.38	3.08	2.20	0.88	2.20	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	30.36	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	21.19	0.21	0.42	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	0.33	0.33	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	27.19	0.27	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.88	0.54	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.73	0.93	0.00	0.00	0.74	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	84.70	0.87	0.65	0.00	0.87	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	132.61	1.47	0.21	0.21	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	196.68	1.52	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	253.45	2.60	0.87	0.00	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	452.81	1.74	2.18	1.31	2.61	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	338.00	1.98	0.99	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	209.56	1.85	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	171.69	1.40	5.58	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	353.91	1.66	0.00	0.28	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	438.27	1.47	0.25	0.00	1.47	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	349.58	0.00	3.08	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	416.85	1.43	2.15	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	391.95	1.38	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	165.99	1.31	0.65	0.33	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	169.32	0.38	0.75	0.00	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	118.42	0.00	0.00	0.00	1.77	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	0.23	0.00	0.00	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	22.05	0.24	0.00	0.00	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.72	0.27	0.55	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	29.72	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.56	0.72	0.24	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.24	0.45	0.45	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.55	0.22	0.43	0.00	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.16	0.00	0.26	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.39	0.47	0.47	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.98	0.30	0.60	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.73	0.87	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.71	1.07	0.53	0.00	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	15.76	0.00	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	0.46	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	1.49	0.00	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.69	0.00	0.36	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	24.46	0.00	0.29	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.92	0.71	0.47	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.89	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.53	0.31	0.31	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	25.33	0.32	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	23.33	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	0.00	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.96	0.00	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.07	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.19	1.40	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	564.77	21.93	9.14	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	339.93	16.80	2.47	7.41	3.95	0.99
Cardiac Myocyte, donor3	11686-122I3	596.04	9.89	5.58	2.21	1.16	0.00
Chondrocyte - de diff, donor1	11261-116G1	557.09	21.15	1.73	5.20	2.77	0.69
Chondrocyte - de diff, donor2	11338-117F6	245.92	5.69	1.78	0.36	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	368.64	8.08	3.87	0.80	3.30	0.46
Chondrocyte - re diff, donor2	11339-117F7	1226.50	25.07	10.74	11.64	6.27	0.90
Chondrocyte - re diff, donor3	11411-118E7	396.72	8.49	4.85	0.40	4.85	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	364.93	17.44	8.95	3.67	1.26	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	300.55	17.10	6.41	8.55	2.99	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	298.50	11.68	6.37	2.92	2.48	1.15
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	137.55	4.13	4.49	0.18	0.09	0.00
Corneal Epithelial Cells, donor1	11526-119I5	33.59	3.73	1.10	0.66	0.00	0.66
Corneal Epithelial Cells, donor2	11606-120I4	35.27	2.28	2.28	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	51.38	6.90	3.58	0.26	0.00	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	181.94	27.74	2.64	3.96	1.16	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	182.62	28.39	2.52	3.15	2.52	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	162.18	13.80	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	151.62	14.15	1.19	3.24	1.40	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.81	0.00	0.00	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	58.76	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	58.07	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	201.79	8.17	3.34	8.51	0.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	193.05	9.98	0.59	3.52	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	149.60	8.48	1.70	10.18	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	296.07	9.83	3.15	8.65	0.39	1.57
Endothelial Cells - Artery, donor1	11264-116G4	224.55	3.49	2.04	2.04	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	250.81	13.41	2.12	9.65	2.82	2.12
Endothelial Cells - Artery, donor3	11413-118E9	230.01	6.84	3.51	8.24	0.88	1.93
Endothelial Cells - Lymphatic, donor1	11236-116D3	375.48	6.87	5.10	7.09	1.99	1.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	517.25	6.69	3.65	17.34	2.13	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	736.61	14.66	3.95	20.58	1.69	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	224.93	8.02	1.19	2.97	0.59	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	180.67	12.50	2.60	17.18	2.60	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	112.58	5.10	0.57	1.28	0.85	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	399.72	14.80	1.20	16.40	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	226.42	4.72	1.05	7.86	1.57	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	559.98	12.67	5.96	12.18	2.36	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	422.57	8.69	3.48	11.08	0.65	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	430.87	10.50	3.66	3.30	1.59	1.71
Endothelial Cells - Vein, donor1	11267-116G7	121.71	6.83	0.00	6.83	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	82.42	6.29	1.40	4.89	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	253.10	10.99	2.04	9.26	1.57	1.88
Eosinophils, donor1	12244-129H3	289.69	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	34.66	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	28.34	5.13	0.98	0.73	0.00	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	10.40	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	227.76	0.00	0.00	32.54	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	1042.30	46.39	5.34	6.16	9.03	4.52
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	390.76	31.86	6.35	15.22	7.77	4.16
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	51.35	8.34	0.98	0.76	0.65	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	690.93	34.56	10.07	11.04	3.52	2.55
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1587.98	56.91	17.06	27.16	6.14	11.87
Fibroblast - Aortic Adventitial, donor2	11326-117E3	625.75	25.21	7.91	4.96	6.64	1.79
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2388.54	35.31	15.55	17.39	16.60	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	683.67	20.93	8.30	6.31	9.30	3.32
Fibroblast - Cardiac, donor1	11268-116G8	381.05	7.71	7.26	2.27	2.27	0.91
Fibroblast - Cardiac, donor2	11345-117G4	221.32	25.01	3.03	7.58	3.03	4.55
Fibroblast - Cardiac, donor3	11417-118F4	334.83	14.35	4.42	3.15	2.68	1.89
Fibroblast - Cardiac, donor4	11452-119A3	649.26	17.88	5.46	3.64	1.52	0.61
Fibroblast - Cardiac, donor5	11456-119A7	623.86	23.60	2.92	12.82	2.66	2.79
Fibroblast - Cardiac, donor6	11460-119B2	492.38	20.62	2.73	11.37	1.97	1.52
Fibroblast - Choroid Plexus, donor1	11492-119E7	141.36	10.59	0.94	2.41	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	278.70	14.67	2.16	1.29	3.88	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	462.87	13.18	7.32	0.00	14.65	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	74.73	2.77	1.61	0.23	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	245.25	9.16	3.39	1.02	1.02	0.00
Fibroblast - Dermal, donor1	11269-116G9	326.11	16.67	1.64	4.93	2.35	3.52
Fibroblast - Dermal, donor2	11346-117G5	125.47	10.85	1.89	1.42	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	254.47	14.87	2.66	2.90	2.06	1.21
Fibroblast - Dermal, donor4	11450-119A1	314.15	10.40	3.05	2.15	1.36	0.90
Fibroblast - Dermal, donor5	11454-119A5	354.49	10.12	2.62	1.05	1.22	1.40
Fibroblast - Dermal, donor6	11458-119A9	427.17	8.77	3.25	1.14	0.97	1.46
Fibroblast - Gingival, donor1	11237-116D4	498.09	16.66	5.62	4.58	1.67	3.12
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	843.38	20.70	9.96	4.98	4.19	2.10
Fibroblast - Gingival, donor2	11318-117D4	267.78	8.57	2.50	1.58	1.98	0.92
Fibroblast - Gingival, donor3	11394-118C8	472.90	12.38	4.35	1.45	1.26	1.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	742.81	15.58	6.23	3.12	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	451.43	9.16	3.52	0.70	4.41	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	539.25	15.59	5.92	2.65	1.87	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	615.83	23.66	7.84	4.06	3.65	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	165.15	20.47	1.76	3.88	0.35	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	752.87	38.02	8.48	14.33	2.05	2.78
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	699.36	19.63	8.59	2.86	4.23	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	641.49	16.45	7.35	4.72	3.18	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	493.04	8.07	2.93	0.59	1.91	0.29
Fibroblast - Lung, donor1	11270-116H1	53.01	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	317.83	8.95	4.48	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	173.68	6.33	2.11	0.42	1.48	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	69.97	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	100.70	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	20.15	0.28	0.00	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	147.37	6.50	2.84	2.03	0.41	0.81
Fibroblast - Mammary, donor2	11620-122A9	47.93	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	160.82	23.83	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	456.03	13.38	9.50	3.69	1.75	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	454.59	13.95	6.22	1.67	0.91	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	891.04	34.88	6.43	11.63	1.84	4.90
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	604.11	14.50	3.05	3.43	1.91	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	469.51	19.98	6.48	1.89	4.86	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	592.28	11.60	7.07	1.39	1.51	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	493.09	21.44	5.86	4.53	1.66	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	79.85	5.89	2.03	0.61	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	70.16	2.67	1.34	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	252.64	9.88	3.95	2.37	0.79	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1439.54	17.86	9.13	9.13	8.73	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	749.90	12.97	5.15	1.60	2.66	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	1149.60	17.15	11.04	2.17	7.29	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1902.00	31.89	10.83	9.03	12.34	2.71
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1386.31	20.62	7.12	4.97	4.75	1.62
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	881.46	15.44	4.05	3.04	4.81	1.27
Fibroblast - skin normal, donor1	11553-120C5	762.47	23.30	5.58	5.74	2.79	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3010.82	54.54	28.27	21.05	9.42	4.41
Fibroblast - skin normal, donor2	11561-120D4	1329.11	26.82	6.03	11.75	5.63	3.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	1282.09	18.44	7.56	8.76	7.86	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	870.46	17.98	8.28	3.40	3.98	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	870.48	19.66	1.37	6.84	4.62	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1903.92	25.62	8.87	8.87	10.18	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1140.64	23.54	6.39	7.46	4.69	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	563.90	16.36	6.75	4.05	3.04	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	737.52	14.90	5.33	5.02	6.90	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1905.74	44.32	0.00	22.16	66.48	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.88	1.74	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	442.76	48.89	10.05	16.82	2.43	7.97
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	699.53	46.32	9.63	36.95	1.30	10.41
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	646.45	56.72	11.50	29.64	2.04	9.20
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	73.49	8.42	2.30	3.83	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.79	9.57	1.91	1.91	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	209.67	17.97	2.85	5.42	1.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	118.85	2.76	4.41	1.38	1.10	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	94.07	4.57	5.02	0.91	1.83	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	146.22	7.93	3.96	1.98	1.19	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	101.50	2.11	3.17	0.79	1.32	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	94.26	2.94	2.61	0.33	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	218.02	12.38	3.10	3.54	2.21	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	125.35	6.08	2.83	2.54	1.13	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	159.84	11.33	4.93	3.20	2.34	1.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	87.30	6.45	4.30	1.61	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	390.64	56.37	13.63	21.56	4.96	7.93
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	442.96	56.06	14.40	23.39	3.88	9.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	271.41	34.97	8.13	11.79	3.86	5.29
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	253.73	31.49	8.21	18.03	2.51	5.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	378.18	31.76	9.34	17.56	3.99	5.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	391.03	30.38	10.05	12.90	1.75	6.56
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	214.22	18.62	5.02	11.52	1.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	262.60	24.64	6.52	16.21	4.13	3.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	245.09	18.32	4.47	8.27	2.68	3.57
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	171.79	11.90	4.23	5.04	2.42	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	233.77	19.68	8.14	10.69	2.21	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	309.20	28.64	8.78	16.23	0.71	4.70
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	217.69	11.34	6.14	4.99	0.73	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	175.05	9.73	2.05	4.44	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	203.60	13.06	4.87	7.19	1.55	2.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	248.09	19.30	7.65	11.48	0.75	3.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	220.72	23.48	3.47	11.64	1.02	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	173.71	9.90	5.16	6.81	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	225.51	10.95	4.96	6.92	2.19	1.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	215.96	12.51	5.67	6.84	2.33	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	158.71	8.60	3.31	2.42	1.98	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	209.82	9.10	3.94	5.90	2.09	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	148.96	9.40	6.00	3.73	1.30	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	148.81	7.06	3.53	3.21	2.25	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	222.01	13.74	5.59	7.86	1.52	1.90
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	202.62	9.97	3.64	6.01	1.74	2.53
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	183.97	9.12	2.74	5.17	2.13	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	261.76	15.89	4.91	9.30	3.35	2.40
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	183.11	9.00	2.85	6.59	1.10	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	165.80	9.26	4.77	5.33	2.24	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	272.76	18.52	3.33	8.52	2.04	2.13
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	188.52	14.17	1.87	6.69	1.60	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	254.60	13.77	4.13	8.72	2.60	2.75
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	251.82	22.02	3.24	11.40	2.46	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	199.78	10.84	3.52	4.34	0.81	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	314.87	15.85	4.61	11.43	4.06	2.21
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	317.35	19.96	4.61	13.82	2.19	2.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	266.78	8.93	1.98	0.00	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	330.70	24.67	3.83	15.57	3.03	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	314.14	15.33	3.63	9.89	4.04	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	290.25	7.12	4.07	2.54	1.27	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	175.37	12.74	2.39	1.99	1.00	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	125.26	3.39	3.70	1.23	1.85	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	147.71	5.93	3.07	1.02	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	45.69	7.82	0.94	3.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	49.73	6.50	1.70	0.85	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	79.33	11.99	0.46	1.84	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	9.90	0.00	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	103.66	11.99	3.87	1.55	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	9.63	4.81	1.60	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	10.43	0.00	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	90.48	10.09	0.98	2.28	1.63	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	126.42	16.88	3.71	3.29	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	113.30	16.66	0.00	3.33	16.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	118.29	9.51	3.36	3.92	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	103.94	8.50	2.94	2.29	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	77.17	9.23	1.68	0.84	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	124.37	7.95	1.27	0.95	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	98.84	6.45	3.06	1.70	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	4.18	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	103.66	7.45	5.73	1.72	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	79.92	3.26	1.18	0.59	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	130.45	3.39	3.39	1.69	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	130.06	5.38	2.49	1.24	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	109.54	4.14	0.46	0.92	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	5.27	0.00	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	114.17	5.38	2.31	0.77	1.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	114.74	4.56	0.00	1.96	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	101.66	8.69	1.34	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	112.11	2.31	1.54	0.00	2.70	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	124.61	3.42	1.71	0.68	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	114.30	4.97	2.48	2.48	14.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	121.27	4.25	0.94	1.89	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	109.84	2.41	2.41	0.00	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	108.86	3.05	3.05	2.03	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	120.05	4.79	2.79	0.40	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	140.61	2.47	3.95	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	129.85	3.54	1.18	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	103.85	4.08	1.17	0.58	4.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	111.04	3.07	1.32	0.00	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	113.59	6.78	0.00	0.85	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	90.13	2.98	1.79	0.00	4.18	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	113.55	1.94	2.43	0.00	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	364.08	13.70	2.28	6.85	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	404.59	14.97	4.99	5.82	9.98	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	158.55	16.87	1.12	5.62	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	294.33	3.81	2.85	0.95	2.85	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	243.13	5.85	2.92	2.09	1.67	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	234.52	7.31	5.57	3.25	1.74	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	220.62	8.95	3.04	4.22	2.53	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	226.59	7.28	7.05	4.10	2.73	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	221.90	7.76	4.70	2.08	2.84	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	221.36	7.09	3.01	5.16	2.15	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	219.80	9.47	3.88	4.31	1.94	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	212.34	6.23	3.74	3.11	2.37	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	192.99	6.86	4.12	2.74	2.06	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	186.78	6.73	4.49	3.20	2.24	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	105.77	5.04	0.56	3.36	1.12	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.03	2.60	0.00	0.87	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	224.72	18.51	0.00	10.58	18.51	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	64.90	3.53	1.06	1.41	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	64.66	3.63	0.00	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	353.17	12.24	4.02	9.79	4.20	1.05
Hepatocyte, donor1	11523-119I2	150.11	9.68	0.00	0.00	3.63	0.00
Hepatocyte, donor2	11603-120I1	234.86	6.46	2.15	2.15	4.31	0.00
Hepatocyte, donor3	11684-122I1	244.19	9.20	4.29	0.61	4.91	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	0.00	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	177.40	7.17	2.45	0.17	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	519.88	19.35	9.47	4.39	1.78	1.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	6.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	1.32	1.32	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	21.42	3.15	1.26	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	4.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	2.58	0.65	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	17.11	1.63	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	1.68	0.00	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	0.00	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	15.07	0.00	1.08	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	2.55	1.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	8.57	1.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	21.61	2.47	0.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	1.39	0.00	0.00	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	8.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	9.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	24.41	3.49	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	2.13	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	4.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	262.75	28.40	4.00	7.51	1.31	3.43
Keratinocyte - epidermal, donor2	11349-117G8	60.91	11.13	0.59	1.17	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	375.31	25.27	7.76	4.64	3.79	3.41
Keratinocyte - oral, donor1	11251-116E9	624.91	36.21	14.19	16.01	2.16	4.31
Keratocytes, donor1	11527-119I6	69.11	3.44	1.03	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	55.07	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	221.31	1.58	2.37	0.00	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	254.96	10.99	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	271.84	15.10	4.31	1.08	1.08	3.24
Lens Epithelial Cells, donor2	11609-120I7	304.36	8.30	6.92	5.42	0.81	0.81
Lens Epithelial Cells, donor3	11690-122I7	1035.23	46.42	12.71	17.76	0.61	4.54
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	250.91	6.52	2.13	4.86	2.25	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	125.03	3.91	1.40	2.79	1.67	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	340.48	7.56	2.83	3.31	5.51	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	144.65	1.08	1.61	1.08	1.61	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	104.00	2.84	0.63	1.26	2.21	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	103.72	2.80	0.75	0.86	1.08	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	208.48	6.16	3.69	3.69	2.87	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	55.11	1.52	0.25	0.51	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	121.89	3.24	1.41	1.27	1.83	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	211.21	5.14	2.37	4.75	1.98	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	162.86	4.46	1.16	2.52	1.74	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	51.10	2.04	0.37	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	208.36	4.53	1.74	2.79	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	119.50	3.10	1.67	0.48	1.91	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	105.21	3.43	1.24	1.51	0.82	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	237.13	4.93	3.08	3.70	2.16	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	63.60	1.25	0.31	4.36	2.18	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	108.33	2.20	1.10	2.01	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	184.96	6.58	1.32	3.62	3.62	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	66.48	2.34	0.59	0.59	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	71.94	1.49	1.00	1.24	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	225.02	5.82	3.39	1.94	2.91	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	157.27	5.66	0.81	2.15	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	148.80	3.48	2.88	1.51	1.67	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	158.12	4.67	1.04	2.59	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	191.38	5.65	2.09	2.93	4.61	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	120.00	1.95	1.20	1.05	1.95	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	179.54	4.13	0.69	4.82	3.44	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	139.04	3.20	1.69	4.14	2.26	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	77.08	2.76	0.32	1.17	1.27	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	193.35	7.27	2.42	4.36	5.33	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	107.18	3.31	0.99	3.31	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	96.64	1.98	1.12	1.12	1.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	255.44	3.70	2.96	3.33	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	153.69	4.94	1.73	3.46	2.47	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	80.43	1.92	0.96	0.82	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	240.91	8.04	1.29	4.82	2.89	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	212.12	7.30	1.22	4.26	1.52	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	219.89	4.62	1.68	2.94	2.10	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	214.76	4.62	1.78	4.98	1.78	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	56.23	2.42	0.97	2.42	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	52.28	1.56	0.62	0.31	0.93	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	159.00	5.01	0.72	3.58	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	122.18	4.25	0.33	2.94	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	54.15	1.18	0.00	0.71	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	244.29	6.19	1.73	5.82	1.36	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	76.33	1.79	0.51	1.79	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	115.76	5.37	0.90	0.90	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	22.27	0.74	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	2.54	0.42	0.00	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.29	0.00	0.70	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.55	0.52	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	2.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.69	1.81	0.23	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	33.45	1.45	1.74	0.00	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	47.72	2.25	1.35	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	31.30	2.71	0.54	0.00	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	0.51	0.00	0.00	1.03	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	46.22	2.12	0.35	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.05	3.06	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	57.63	1.87	0.80	0.27	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	53.47	2.46	1.51	0.19	1.32	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	1.84	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.14	0.00	0.00	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	56.64	2.29	1.25	0.00	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.09	1.96	1.40	0.00	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	54.87	1.74	2.03	0.00	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	51.42	2.39	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	61.41	1.11	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.18	1.77	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	37.62	0.74	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	3.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.18	1.54	0.77	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	23.78	1.70	0.57	0.00	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	1.64	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.56	0.45	0.00	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.98	0.72	0.72	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	1.49	0.75	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	37.16	1.11	0.37	0.00	1.86	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	45.66	1.72	0.86	0.00	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	38.53	1.71	0.00	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	32.98	1.00	1.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	22.93	1.21	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.20	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	30.25	1.37	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	23.08	2.68	0.54	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.32	1.35	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.63	1.85	0.37	0.37	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	0.00	0.00	1.16	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	3.17	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	34.01	1.20	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	0.73	0.00	0.73	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.65	0.49	0.99	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	24.46	0.00	1.88	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	4.02	1.51	0.50	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.80	2.25	1.80	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	3.12	0.45	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	32.46	3.13	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	5.28	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	35.81	2.08	0.52	0.52	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	3.94	0.44	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	40.26	3.35	3.35	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.28	3.97	0.88	0.00	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	53.61	5.01	0.77	0.39	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	36.96	3.54	0.51	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	55.27	3.36	2.88	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.95	3.58	0.00	0.00	1.19	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	49.82	1.82	0.00	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.89	0.69	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	50.54	2.28	1.14	1.52	1.52	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	39.25	2.07	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.33	2.42	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	52.61	1.58	2.22	0.63	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	38.38	3.73	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	32.76	2.30	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.54	2.06	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	2.12	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.78	2.84	1.13	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.53	2.08	2.08	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	30.54	1.57	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	34.24	1.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	31.60	2.32	0.46	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	19.40	2.68	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.44	2.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.56	0.00	1.21	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	31.12	2.67	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	1.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	25.31	1.53	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.02	2.19	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.74	0.89	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.93	1.04	1.56	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	41.11	0.66	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	2.08	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	136.52	6.15	0.68	0.00	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	208.83	6.42	3.30	2.57	1.47	0.18
Macrophage - monocyte derived, donor3	11389-118C3	159.26	5.64	2.49	1.05	1.05	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	385.52	24.96	7.43	11.15	0.00	6.90
Mallassez-derived cells, donor2	11929-125I3	1172.23	57.68	11.57	35.18	6.02	9.67
Mallassez-derived cells, donor3	11930-125I4	741.36	37.39	8.34	15.01	1.25	5.28
Mammary Epithelial Cell, donor1	11273-116H4	511.07	62.38	8.47	17.14	2.59	5.08
Mammary Epithelial Cell, donor2	11350-117G9	388.58	46.04	4.34	10.13	2.03	3.76
Mammary Epithelial Cell, donor3	11422-118F9	130.20	5.24	2.74	1.25	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	568.79	3.39	4.07	2.71	0.68	0.00
Mast cell, donor1	11563-120D6	194.22	2.05	1.30	0.00	0.65	0.00
Mast cell, donor2	11565-120D8	210.40	4.16	1.19	0.30	0.00	0.00
Mast cell, donor3	11566-120D9	161.64	2.48	1.80	0.23	0.45	0.00
Mast cell, donor4	11567-120E1	203.53	1.77	1.06	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	240.30	1.22	1.33	0.33	1.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	70.63	1.17	0.58	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	107.04	0.46	1.15	0.00	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	73.31	0.50	0.84	0.17	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	325.36	6.27	2.79	4.08	1.59	0.30
Melanocyte - dark, donor2	11582-120F7	351.62	12.81	4.50	3.46	2.42	1.38
Melanocyte - dark, donor3	11663-122F7	301.50	3.19	3.84	0.87	0.58	0.36
Melanocyte - light, donor1	11274-116H5	54.77	1.88	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	25.93	1.36	0.00	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	49.43	2.60	2.60	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	235.22	3.85	2.81	0.62	2.29	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	200.36	6.45	2.69	0.54	2.15	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	143.03	1.07	0.80	0.00	1.34	0.00
Meningeal Cells, donor1	11493-119E8	146.39	8.06	0.50	2.85	0.37	0.87
Meningeal Cells, donor2	11573-120E7	177.82	8.80	2.20	4.84	0.44	1.76
Meningeal Cells, donor3	11654-122E7	433.18	18.58	6.76	12.80	1.96	2.12
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	269.19	10.84	7.98	3.14	0.29	2.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	723.24	34.82	9.96	19.62	2.01	5.23
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26.28	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	0.00	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	252.60	11.48	2.15	1.44	3.59	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	793.07	28.17	8.89	8.26	4.66	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	502.65	16.59	4.52	3.02	2.51	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	55.60	1.54	0.44	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	2.92	0.00	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	54.02	2.66	0.82	1.02	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	451.95	9.42	1.52	1.39	1.94	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	53.53	2.23	1.49	1.49	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	647.35	15.53	5.39	7.24	4.08	3.03
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	57.27	2.37	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	32.70	4.67	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	71.08	1.28	1.28	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	409.38	14.53	4.25	2.84	1.42	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	620.76	14.07	5.00	9.07	1.56	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	240.20	5.81	1.45	2.90	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	1055.13	41.63	20.68	17.77	3.71	7.69
Mesothelial Cells, donor2	12156-128G5	1071.00	51.55	22.52	26.02	2.00	12.01
Mesothelial Cells, donor3	11402-118D7	708.41	33.82	8.02	11.78	11.13	6.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	220.10	10.80	5.40	1.35	1.35	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	202.44	1.97	1.48	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	132.21	8.24	2.06	1.77	0.59	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	69.14	3.46	6.91	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	135.45	2.48	0.93	2.17	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	101.02	5.39	3.32	0.41	1.04	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	6.95	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	166.67	6.26	0.75	0.75	0.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	130.33	7.91	2.79	0.47	1.40	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	148.75	4.67	0.61	1.22	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	113.25	8.71	1.58	2.38	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	17.10	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	85.84	3.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	101.82	8.36	1.52	1.14	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	75.01	9.21	1.32	1.32	2.63	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	114.39	2.76	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	51.57	9.21	0.92	1.84	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	120.71	3.28	0.89	1.49	2.09	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	70.42	13.41	1.68	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	107.89	4.01	1.00	1.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	93.64	5.94	0.95	1.66	0.95	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	93.99	6.63	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	102.92	3.22	0.46	0.23	1.15	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	102.01	9.04	1.89	1.05	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	102.93	4.89	1.22	1.63	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	101.05	3.22	1.07	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	88.03	6.45	1.33	1.11	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	82.57	3.29	1.10	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	91.25	8.62	1.01	1.01	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	84.51	3.31	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	98.39	2.45	1.09	0.54	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	101.16	7.06	1.76	2.06	0.59	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	57.79	5.45	4.36	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.02	1.44	1.92	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	89.25	4.80	2.00	1.20	0.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	87.76	8.23	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	74.59	0.50	0.50	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	59.12	4.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	83.21	1.75	0.44	1.75	0.44	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	82.77	8.83	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	96.70	3.84	1.28	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	89.99	1.98	0.74	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	91.16	4.18	1.39	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	103.86	8.84	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	111.11	3.08	2.05	0.68	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	94.96	6.13	2.19	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	117.54	5.33	0.36	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	90.62	1.96	0.84	0.84	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	115.96	6.23	1.25	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	90.33	2.33	3.50	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	120.06	4.22	0.60	0.90	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	106.02	2.50	2.50	0.42	1.25	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	120.99	5.54	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	127.48	3.98	2.85	2.85	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	142.74	3.59	1.38	0.69	0.83	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	110.14	2.85	0.52	1.04	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	120.54	3.00	0.86	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	87.66	1.27	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	119.30	2.14	0.80	0.80	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	186.48	6.88	1.50	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	126.28	2.97	1.55	0.71	0.85	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	84.72	2.23	1.27	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	137.76	5.97	2.21	1.55	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	105.42	5.31	1.90	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	114.49	3.98	1.99	1.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	131.01	4.92	2.95	0.98	0.98	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	110.78	2.61	0.65	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	127.31	4.41	0.29	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	151.37	6.34	1.73	0.58	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	168.57	8.24	1.24	0.41	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	119.71	4.76	1.49	0.30	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	78.42	0.00	0.00	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	110.40	0.99	0.99	0.00	1.97	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	75.74	2.10	1.05	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	93.31	1.38	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	115.48	4.66	0.00	0.93	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	132.56	4.13	1.50	0.00	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	92.95	2.13	1.07	0.80	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	103.71	2.71	0.79	0.00	0.68	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	60.41	0.74	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	93.07	0.73	1.10	0.00	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	94.89	3.11	0.00	0.00	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	123.46	2.67	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	54.54	1.01	0.00	0.00	4.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	103.30	3.37	1.69	0.00	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	84.44	6.81	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	51.50	1.27	0.64	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	112.57	0.81	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	93.65	1.51	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	81.56	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	648.46	18.53	6.46	5.60	3.45	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	428.54	4.70	3.66	1.05	4.18	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	332.41	23.36	2.67	4.00	0.00	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	303.85	25.46	1.25	4.17	0.42	3.76
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1189.91	22.06	4.94	11.98	4.18	2.66
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1404.35	49.47	20.75	11.17	0.00	6.38
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	203.98	15.64	1.36	4.08	1.36	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1701.66	77.18	23.89	18.38	20.21	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	277.49	20.93	3.77	4.19	1.26	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	419.78	21.62	2.32	2.09	0.93	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	275.90	14.59	2.16	4.05	1.35	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	583.20	16.19	4.84	5.47	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	2071.06	55.67	55.67	0.00	66.81	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	242.72	16.88	4.47	6.95	1.99	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	658.54	18.68	3.52	4.33	2.17	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	250.03	20.85	0.91	2.95	0.91	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	291.66	13.55	2.12	3.27	0.98	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	504.48	8.93	7.29	1.28	2.37	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	267.34	13.79	2.12	2.65	1.59	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	213.71	13.81	0.60	3.00	0.60	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1300.57	20.68	3.94	2.95	7.88	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	244.26	16.10	2.60	2.11	0.16	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	605.34	13.76	5.12	0.88	1.23	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	246.13	11.25	1.41	5.63	3.52	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	302.49	15.17	0.92	3.22	1.84	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	381.76	12.21	2.25	0.96	1.61	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1235.39	18.28	3.45	2.07	11.73	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2890.01	37.93	25.28	5.06	20.23	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	519.53	9.58	3.12	1.56	1.11	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	304.84	11.43	1.69	4.23	3.39	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	452.15	9.73	1.66	1.66	1.19	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	432.68	8.58	3.00	3.00	0.86	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	2852.77	9.03	9.03	0.00	90.28	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	365.88	10.66	1.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	440.04	10.82	7.21	0.90	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	284.51	8.73	2.38	4.76	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	218.23	8.36	2.79	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	727.99	12.11	2.65	1.14	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	245.07	8.47	1.30	1.96	3.58	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	189.13	2.61	3.49	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	776.12	13.12	6.33	7.24	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	252.23	13.23	0.00	3.53	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	232.03	13.96	1.33	1.99	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	368.56	7.44	1.98	2.48	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	210.17	9.57	0.38	1.53	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	634.83	3.63	3.33	0.91	2.12	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	733.80	9.06	7.96	5.08	3.09	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	229.05	8.13	0.68	2.71	1.36	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1435.78	15.33	25.55	0.00	35.77	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	353.01	4.27	3.05	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	280.43	6.92	0.63	1.89	1.26	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	174.93	1.21	0.61	0.30	1.21	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	359.97	12.66	3.96	3.96	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	1254.94	13.60	3.40	2.27	22.67	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1431.38	10.12	0.00	15.17	35.41	5.06
Myoblast, donor1	11241-116D8	589.46	31.80	10.56	14.04	4.10	5.34
Myoblast, donor2	11322-117D8	510.35	20.14	7.48	1.92	5.37	1.53
Myoblast, donor3	11398-118D3	761.27	23.71	10.93	5.04	2.02	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	51.66	0.29	0.00	0.15	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	203.27	0.62	1.23	0.31	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	204.46	3.02	0.30	0.30	1.51	0.30
Natural Killer Cells, donor3	11387-118C1	177.06	0.92	0.37	0.18	1.10	0.37
Neural stem cells, donor1	11275-116H6	276.20	7.26	9.80	0.73	1.09	0.00
Neural stem cells, donor2	11352-117H2	248.41	1.93	15.41	0.00	0.00	0.00
Neurons, donor1	11494-119E9	102.41	0.00	6.83	0.00	0.00	0.00
Neurons, donor2	11574-120E8	101.05	2.20	3.52	1.10	0.88	0.00
Neurons, donor3	11655-122E8	107.70	0.82	3.29	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	27.84	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	34.79	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	64.75	0.61	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	395.39	5.70	5.34	0.24	1.42	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	103.54	2.93	1.30	0.65	2.60	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	272.95	7.22	0.80	1.00	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	650.82	34.00	4.54	14.45	7.16	2.06
Olfactory epithelial cells, donor2	11934-125I8	745.58	27.36	4.49	5.21	8.25	4.78
Olfactory epithelial cells, donor3	11935-125I9	579.67	22.25	3.29	8.06	4.09	3.18
Olfactory epithelial cells, donor4	11936-126A1	893.43	37.79	8.86	5.26	3.99	2.34
Oligodendrocyte - precursors, donor1	11496-119F2	683.67	12.04	12.64	6.02	3.01	1.20
Osteoblast - differentiated, donor1	11276-116H7	202.06	11.27	1.49	1.49	0.43	1.06
Osteoblast - differentiated, donor2	11353-117H3	117.74	3.43	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	115.45	4.34	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	123.13	8.21	2.35	3.32	0.20	0.98
Osteoblast, donor2	11354-117H4	965.69	36.52	14.05	8.43	2.81	0.70
Osteoblast, donor3	11426-118G4	456.94	22.04	7.29	4.09	1.96	3.38
Pancreatic stromal cells, donor1	11249-116E7	603.13	15.42	5.90	3.45	2.19	0.67
Pericytes, donor1	11491-119E6	19.69	1.56	0.11	0.67	0.11	0.00
Pericytes, donor2	11571-120E5	20.83	0.68	0.00	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	88.70	5.29	1.42	0.61	0.61	1.02
Perineurial Cells, donor1	11499-119F5	676.09	19.10	9.04	5.31	2.03	0.34
Perineurial Cells, donor2	11579-120F4	678.86	18.77	8.47	6.72	2.12	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	178.49	1.59	0.96	0.00	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	83.01	0.49	0.73	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	132.39	0.78	0.65	0.13	0.39	0.39
Placental Epithelial Cells, donor1	11278-116H9	34.20	0.48	0.24	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	107.56	7.76	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	66.75	2.55	0.79	0.98	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	489.87	18.67	4.11	4.43	9.81	0.63
Preadipocyte - breast, donor1	11467-119B9	664.25	23.26	6.57	5.06	4.31	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1214.69	23.10	9.14	4.44	3.26	1.04
Preadipocyte - breast, donor2	11328-117E5	705.17	22.97	8.33	5.18	8.33	2.03
Preadipocyte - omental, donor1	11468-119C1	734.30	28.88	10.12	7.03	4.37	1.60
Preadipocyte - omental, donor2	11329-117E6	1206.40	33.17	12.66	8.73	9.17	4.80
Preadipocyte - omental, donor3	11403-118D8	838.00	25.50	12.32	5.16	7.16	3.29
Preadipocyte - perirenal, donor1	11469-119C2	332.68	11.81	0.98	0.98	2.95	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	196.25	29.18	3.99	7.68	0.31	3.99
Preadipocyte - subcutaneous, donor2	11356-117H6	652.35	31.34	7.44	5.31	6.73	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	747.55	41.72	8.51	11.58	4.43	4.26
Preadipocyte - visceral, donor1	11280-116I2	952.25	66.32	10.06	11.08	3.63	4.01
Preadipocyte - visceral, donor2	11357-117H7	801.17	62.58	2.76	8.74	8.28	5.06
Preadipocyte - visceral, donor3	11429-118G7	580.03	33.65	3.55	5.12	3.87	2.19
Prostate Epithelial Cells (polarized), donor1	11253-116F2	166.69	4.22	3.02	0.60	0.60	0.00
Prostate Epithelial Cells, donor2	11331-117E8	523.10	39.54	6.23	25.86	4.74	12.73
Prostate Epithelial Cells, donor3	11404-118D9	305.64	6.12	5.57	2.27	6.43	1.04
Prostate Stromal Cells, donor1	11254-116F3	410.27	17.77	6.49	3.64	2.39	1.59
Prostate Stromal Cells, donor2	11332-117E9	356.45	16.50	3.77	2.69	5.20	0.90
Prostate Stromal Cells, donor3	11405-118E1	256.41	7.51	1.56	0.83	2.29	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	100.37	2.55	0.73	1.09	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	872.84	53.72	26.41	18.16	4.30	8.11
Renal Epithelial Cells, donor1	11517-119H5	41.59	6.09	2.54	2.03	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	61.17	2.13	2.13	2.13	1.42	1.42
Renal Epithelial Cells, donor3	11678-122H4	993.44	94.96	24.88	45.10	6.67	18.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	41.53	2.04	0.00	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	97.57	4.31	0.81	5.26	0.40	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	477.99	16.43	3.33	11.99	4.66	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	37.93	2.00	0.00	1.33	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	87.60	5.94	1.54	1.76	0.22	1.76
Renal Mesangial Cells, donor2	11598-120H5	78.37	5.64	0.63	0.63	0.00	1.88
Renal Mesangial Cells, donor3	11679-122H5	31.62	1.66	1.11	0.55	0.00	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	158.10	8.32	4.56	3.22	0.81	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	77.59	4.22	2.11	2.11	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	99.12	9.45	2.89	2.70	0.39	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	144.16	2.85	5.44	1.04	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	48.04	0.57	0.85	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	146.78	2.01	2.76	0.25	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	326.74	11.63	4.54	1.74	0.94	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	158.13	0.89	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	126.03	1.10	2.20	0.00	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	236.66	2.32	2.32	0.58	2.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	248.87	1.69	0.52	0.39	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	162.07	2.09	1.59	0.20	1.09	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	196.53	2.12	2.01	0.00	0.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	333.80	2.48	2.48	0.37	2.48	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	160.37	1.86	1.63	0.00	1.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	208.94	1.16	3.70	0.00	2.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	176.06	0.41	1.10	0.68	1.78	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	170.64	1.66	1.66	0.15	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	155.90	1.43	2.87	0.18	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	168.56	1.58	1.29	0.43	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	155.50	0.97	2.68	0.11	0.54	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	180.78	1.77	2.21	0.00	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	164.22	2.29	1.53	0.00	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	190.89	1.12	1.96	0.47	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	214.21	1.32	2.63	0.38	1.13	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	236.09	1.46	2.39	0.00	0.93	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	193.32	1.36	3.11	0.39	1.56	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	183.13	1.72	1.53	0.57	0.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	214.44	2.35	1.39	0.00	0.53	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	157.81	2.24	0.84	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	181.67	1.37	2.73	0.00	2.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	196.37	0.73	0.36	0.36	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	152.92	1.47	1.47	0.00	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	177.57	2.15	2.69	0.27	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	151.90	1.42	1.18	0.00	2.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	163.29	1.39	1.79	0.00	0.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	182.87	1.17	2.10	0.00	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	163.81	0.83	0.83	0.62	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	179.18	2.88	2.88	0.00	0.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	179.85	0.63	1.46	0.00	1.25	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	198.11	2.02	1.21	0.54	1.35	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	217.13	1.02	3.92	0.34	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	193.57	0.96	2.31	0.19	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	156.98	0.69	0.69	0.00	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	203.97	1.65	3.15	0.41	1.65	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	186.00	1.81	1.97	0.00	1.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	184.07	0.85	1.02	0.34	2.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	198.56	2.52	2.81	0.15	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	186.85	1.60	3.47	0.53	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	198.97	1.38	1.66	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	177.86	2.86	4.05	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	281.75	2.02	3.63	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	182.13	1.32	1.88	0.00	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	169.44	1.75	2.10	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	211.25	2.12	4.23	0.00	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	192.76	1.71	1.22	0.24	1.22	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	299.84	3.35	3.93	0.15	1.60	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	209.30	1.83	3.04	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	169.69	3.01	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	228.22	1.58	3.62	0.23	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	228.25	2.10	3.59	0.00	1.80	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	241.23	2.24	1.65	0.12	1.18	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	216.86	1.49	2.56	0.00	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	240.39	3.00	2.40	0.60	2.40	0.00
Schwann Cells, donor1	11498-119F4	63.38	3.95	0.94	0.75	0.00	0.56
Schwann Cells, donor2	11578-120F3	282.40	6.80	6.80	6.80	3.40	0.00
Schwann Cells, donor3	11659-122F3	298.61	11.61	3.72	5.92	9.42	1.97
Sebocyte, donor1	11220-116B5	386.18	28.48	10.96	10.41	1.64	6.57
Sebocyte, donor2	11301-117B5	233.91	26.65	4.60	9.19	1.38	5.06
Sebocyte, donor3	11378-118B1	83.48	2.06	0.82	0.62	0.21	0.62
Sertoli Cells, donor1	11255-116F4	1418.05	31.48	8.28	8.28	8.28	3.31
Sertoli Cells, donor2	11333-117F1	581.82	16.95	2.82	11.30	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	303.61	7.65	3.17	0.97	0.88	0.88
Skeletal Muscle Cells, donor2	11358-117H8	34.70	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	160.52	15.88	4.18	1.67	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	313.87	12.72	2.51	2.04	2.04	0.63
Skeletal Muscle Cells, donor5	11455-119A6	291.19	11.59	2.08	2.53	1.19	0.59
Skeletal Muscle Cells, donor6	11459-119B1	349.51	10.16	3.23	2.00	2.46	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	477.06	14.24	6.05	2.14	1.89	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	334.60	8.99	5.28	0.57	1.28	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	373.92	11.71	7.64	3.87	2.78	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	264.80	6.15	4.38	0.84	1.35	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	113.63	7.96	0.72	1.45	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	171.45	7.43	1.93	1.38	0.69	0.69
Skin - palm, donor1	10286-104F7	220.26	2.69	8.06	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	215.95	12.69	3.03	4.90	3.32	2.16
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	188.93	30.26	1.64	8.18	1.64	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	146.19	12.72	1.17	5.71	0.91	2.34
Small Airway Epithelial Cells, donor1	11256-116F5	737.58	49.49	14.60	19.46	4.31	7.51
Small Airway Epithelial Cells, donor2	11334-117F2	679.37	46.84	9.85	16.60	3.66	8.16
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	685.72	32.14	12.26	12.69	2.96	7.40
Small Airway Epithelial Cells, donor3	11406-118E2	498.12	13.79	7.20	7.35	4.20	2.55
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	100.29	12.34	1.23	2.16	0.31	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3290.28	119.84	19.34	50.91	15.34	16.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	533.16	54.08	9.99	20.57	0.00	5.29
Smooth Muscle Cells - Aortic, donor1	11283-116I5	260.99	14.36	5.75	4.86	1.55	2.65
Smooth Muscle Cells - Aortic, donor2	11360-117I1	244.14	28.35	5.12	11.81	1.97	4.73
Smooth Muscle Cells - Aortic, donor3	11432-118H1	528.44	74.94	10.04	14.68	2.32	12.36
Smooth Muscle Cells - Bladder, donor1	11519-119H7	169.13	3.00	0.00	0.00	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	504.90	62.81	10.25	26.22	2.53	8.52
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	892.82	51.65	10.42	13.74	8.20	5.98
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	715.31	68.37	4.35	33.42	1.66	13.70
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	287.50	14.33	3.58	7.81	0.00	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	581.79	25.40	5.91	7.97	0.59	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	447.45	21.78	5.55	6.69	2.99	3.84
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.36	0.98	0.33	0.16	0.00	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	291.04	4.26	5.18	1.22	1.52	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	391.73	33.34	9.85	9.85	1.77	4.80
Smooth Muscle Cells - Carotid, donor2	11362-117I3	165.26	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	266.55	26.70	1.91	6.68	0.95	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	304.24	8.26	3.83	2.65	1.77	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	283.25	8.18	7.10	1.72	1.72	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	333.45	8.71	4.51	1.68	2.20	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	225.68	25.06	4.33	8.97	0.62	5.72
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	214.50	25.87	2.16	9.70	1.08	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	499.09	33.17	3.59	14.64	1.79	6.87
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.09	1.37	2.05	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	509.34	8.56	6.99	1.96	2.98	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	877.29	61.09	19.42	12.88	5.33	6.24
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	974.38	49.83	10.24	15.93	10.69	7.05
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	253.00	16.91	1.21	6.04	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	466.53	19.34	6.36	6.36	2.12	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	602.68	12.25	3.33	3.46	2.66	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	417.98	12.65	5.38	3.13	6.14	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	353.35	7.61	1.27	0.25	1.78	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	617.42	47.34	9.35	15.68	2.86	5.88
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	420.09	21.75	4.50	3.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	115.01	6.46	0.00	5.17	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	379.96	60.92	8.37	17.21	1.40	11.16
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	570.01	42.41	5.55	12.12	4.54	5.55
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	429.66	41.05	2.82	13.79	1.88	7.21
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	38.64	1.77	0.29	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	624.05	19.58	9.41	5.50	1.08	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	278.43	5.61	3.27	0.93	2.34	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	359.51	39.29	6.48	16.98	0.72	6.48
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	227.68	10.71	2.04	4.33	2.55	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	197.25	14.48	1.32	4.89	0.56	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	747.21	16.21	8.52	4.33	1.82	1.54
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	713.12	9.89	5.03	3.69	1.59	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	26.19	0.95	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	393.91	34.99	8.56	11.74	0.73	5.63
Smooth Muscle Cells - Uterine, donor1	11258-116F7	982.11	45.29	6.63	19.66	5.52	5.97
Smooth Muscle Cells - Uterine, donor3	11466-119B8	515.23	17.55	7.61	4.39	2.93	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	265.30	4.47	2.53	0.19	1.75	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	441.64	15.87	4.23	5.29	4.50	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	361.90	7.81	2.60	1.12	2.98	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	480.43	18.69	7.19	15.45	7.91	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	404.27	23.85	4.26	13.63	4.26	5.68
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	462.01	14.57	4.73	6.30	5.12	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	628.02	29.71	3.56	10.41	7.87	4.32
Smooth muscle cells - airway, control, donor2	11967-126D5	423.68	14.38	2.40	4.39	6.39	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	225.72	7.52	0.84	0.84	3.34	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	235.14	2.75	2.75	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	786.23	40.57	9.76	6.23	5.22	1.68
Synoviocyte, donor2	11368-117I9	436.83	10.56	4.36	0.67	3.69	0.84
Synoviocyte, donor3	11440-118H9	341.59	5.14	0.67	0.22	2.01	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	66.46	2.50	1.43	1.43	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	61.44	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	62.05	1.62	0.23	0.46	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	249.75	21.94	4.44	6.45	0.79	3.51
Tracheal Epithelial Cells, donor2	11369-118A1	76.15	17.01	1.16	3.09	0.77	5.41
Tracheal Epithelial Cells, donor3	11441-118I1	70.44	11.45	1.15	2.29	0.00	4.01
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	314.33	7.26	5.41	1.11	0.86	0.37
Urethra, donor2	10319-105A4	336.31	1.80	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	44.63	11.16	1.33	4.25	0.00	1.33
Urothelial Cells, donor2	11600-120H7	55.68	6.01	0.40	2.80	1.20	1.60
Urothelial Cells, donor3	11681-122H7	46.30	5.27	1.38	2.29	0.69	0.69
Urothelial cells, donor0	11216-116B1	1081.26	76.01	20.95	57.28	4.24	12.26
Whole blood (ribopure), donor090309, donation1	12179-129A1	373.71	1.78	0.00	0.89	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	325.95	2.86	0.00	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	164.28	0.68	2.05	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	183.19	2.07	0.34	0.00	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	173.73	1.16	0.58	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	274.89	2.08	0.00	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	316.64	1.84	0.00	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	210.88	1.83	0.00	0.00	3.65	0.00
Wilms' tumor cell line:G-401	10809-111A8	161.48	17.39	2.22	9.62	2.10	4.44
Wilms' tumor cell line:HFWT	10597-108E3	727.79	37.84	18.48	24.64	0.88	18.48
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	200.27	6.14	0.84	0.84	0.84	0.56
achilles tendon, donor2	10292-104G4	196.32	4.13	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	71.90	1.02	0.51	0.25	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	59.90	0.00	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	95.09	0.24	1.31	0.00	0.71	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	94.42	0.00	2.99	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	56.22	0.56	0.84	0.00	1.69	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	101.09	1.06	2.11	0.42	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	98.00	0.54	1.63	0.27	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	145.85	3.53	0.88	1.32	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	97.19	1.63	1.23	0.41	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.82	0.39	0.78	0.00	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.10	0.37	0.37	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	84.12	1.63	0.46	0.23	0.93	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	20.45	0.00	0.00	0.00	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	29.81	0.29	0.00	0.00	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.14	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	87.60	2.06	1.23	0.00	2.06	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.64	2.15	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	77.23	2.56	2.56	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	85.23	3.03	0.91	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	86.89	1.44	0.96	1.20	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	36.75	0.22	0.45	0.00	0.89	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	68.38	1.00	1.00	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	354.92	16.72	7.43	11.15	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	97.93	0.75	1.13	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	129.97	7.41	1.31	0.87	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	189.32	3.75	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	160.85	15.31	1.88	0.47	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	420.68	8.84	4.50	1.24	1.86	0.62
adipose, donor1	10184-103D4	283.24	7.04	12.31	0.59	1.17	0.59
adipose, donor2	10185-103D5	52.72	2.03	1.22	0.41	0.81	0.00
adipose, donor3	10186-103D6	103.47	4.90	2.45	4.08	0.27	0.82
adipose, donor4	10187-103D7	124.81	10.40	1.73	2.60	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	309.17	17.68	6.31	9.00	1.10	2.21
adrenal gland, adult, pool1	10081-102A9	101.85	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	749.48	8.00	15.07	3.34	1.73	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	294.77	32.87	0.71	6.43	3.57	3.57
amniotic membrane cells, donor1	12235-129G3	531.86	2.32	5.56	0.70	2.32	0.23
amniotic membrane cells, donor2	12236-129G4	336.75	3.04	0.68	0.00	2.37	0.34
amniotic membrane cells, donor3	12237-129G5	445.73	0.29	3.24	0.00	2.95	0.00
amygdala - adult, donor10196	10167-103B5	45.06	0.00	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	77.05	0.61	1.62	0.00	1.01	0.00
amygdala, newborn, donor10223	10360-105E9	50.35	0.97	1.29	0.32	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	599.72	15.79	5.98	6.75	2.29	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	33.31	0.22	0.44	0.00	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	50.44	0.00	1.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	642.14	4.71	7.26	0.20	5.10	0.39
appendix, adult	10189-103D9	151.75	4.27	1.94	0.00	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	99.05	3.10	1.72	0.00	0.34	0.34
artery, adult	10190-103E1	235.05	1.36	5.43	0.00	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	291.62	10.87	4.20	2.46	1.01	0.87
b cell line:RPMI1788	10427-106D4	2.53	0.00	0.15	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	1570.91	97.94	18.31	66.59	8.32	14.15
bile duct carcinoma cell line:HuCCT1	10432-106D9	364.78	23.42	4.66	15.58	0.89	3.47
bile duct carcinoma cell line:TFK-1	10496-107C1	241.69	7.70	2.18	4.02	1.67	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	33.55	1.12	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	420.33	2.50	7.50	0.22	1.74	0.22
blood, adult, pool1	10053-101G8	205.96	0.00	0.00	0.00	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	866.62	51.38	0.86	5.99	0.00	0.00
bone marrow, adult	10192-103E3	264.53	2.70	1.35	3.37	0.67	0.00
brain, adult, donor1	10084-102B3	20.50	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	61.69	1.11	2.23	0.33	0.11	0.00
brain, fetal, pool1	10085-102B4	24.04	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	174.43	1.98	1.65	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	122.58	0.75	2.00	0.00	0.37	0.00
breast, adult, donor1	10080-102A8	404.07	2.53	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	184.46	10.16	0.38	0.38	1.14	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	146.57	4.33	1.24	0.62	2.47	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	355.69	16.35	2.53	3.22	4.60	2.07
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	120.56	4.12	0.73	0.48	1.69	0.24
carcinoid cell line:NCI-H1770	10703-109H1	60.18	1.41	0.47	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	239.32	8.31	2.41	2.19	1.64	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	72.57	0.00	1.58	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	157.04	3.19	2.13	0.00	1.06	0.00
caudate nucleus - adult, donor10196	10177-103C6	62.17	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	54.72	0.00	1.17	0.17	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	39.74	0.76	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	38.09	0.37	0.37	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	55.35	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	52.74	0.00	2.14	0.00	0.85	0.00
cerebellum, adult, pool1	10083-102B2	22.42	1.38	1.03	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	51.48	0.00	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	85.73	1.01	0.76	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	68.70	1.46	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	212.08	1.58	2.30	0.72	0.72	0.29
cervical cancer cell line:ME-180	10553-107I4	280.06	11.10	3.98	5.30	0.33	1.16
cervix, adult, pool1	10013-101C4	330.51	1.47	6.40	0.31	0.42	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	548.30	5.99	4.88	0.70	1.39	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	1402.92	61.39	11.76	7.84	1.31	6.53
choriocarcinoma cell line:BeWo	10423-106C9	188.90	4.23	3.85	0.37	0.75	0.00
choriocarcinoma cell line:SCH	10785-110H2	153.03	13.43	1.60	0.99	1.85	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	110.76	0.71	3.56	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	425.67	4.56	3.42	0.85	3.42	0.85
chorionic membrane cells, donor2	12239-129G7	827.67	21.78	8.25	8.65	2.98	2.59
chorionic membrane cells, donor3	12240-129G8	687.95	14.29	2.75	2.20	8.24	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	0.00	0.00	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	167.89	0.58	1.15	0.58	0.96	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	113.83	1.90	1.48	0.63	0.63	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	80.89	2.82	0.77	0.26	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	89.49	3.87	1.94	0.00	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	94.68	2.85	2.04	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	142.52	4.12	0.88	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	168.10	0.52	2.61	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	303.78	48.23	2.29	11.66	3.43	5.94
clear cell carcinoma cell line:TEN	10636-108I6	286.46	15.79	2.78	4.51	0.69	2.08
colon carcinoma cell line:CACO-2	10513-107D9	263.76	11.35	4.21	1.10	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	132.27	4.56	1.52	0.76	0.00	0.38
colon, adult, donor1	10082-102B1	190.41	5.95	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	253.92	7.29	3.76	0.47	0.47	0.47
colon, fetal, donor1	10070-101I7	341.75	6.80	3.71	1.85	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	50.42	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	62.04	2.97	1.27	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	68.82	1.06	0.75	0.00	0.75	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	79.39	0.56	1.27	0.42	0.71	0.00
corpus callosum, adult, pool1	10042-101F6	112.33	1.11	3.98	0.33	0.00	0.00
cruciate ligament, donor2	10295-104G7	230.17	5.67	1.62	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	278.49	1.61	1.61	0.00	1.61	0.00
diencephalon, adult	10193-103E4	64.32	0.00	0.72	0.00	0.72	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	48.91	0.00	0.00	0.00	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	187.20	12.05	2.56	1.54	0.51	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	380.58	17.81	4.81	14.20	2.17	2.89
ductus deferens, adult	10196-103E7	389.70	20.93	5.98	6.48	3.49	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	254.92	5.76	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	235.41	3.68	5.15	1.47	6.62	0.00
dura mater, adult, donor1	10041-101F5	215.39	5.04	4.29	0.41	0.33	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	41.31	5.77	1.78	2.44	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	70.79	1.72	4.30	0.14	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	355.79	20.96	1.23	2.47	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	244.29	30.88	3.03	8.78	1.21	5.15
embryonic pancreas cell line:1C3IKEI	10606-108F3	337.77	23.46	1.54	4.63	1.23	2.78
embryonic pancreas cell line:2C6	10603-108E9	387.47	13.13	1.31	9.19	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	151.17	3.69	2.68	0.34	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	930.28	54.19	14.14	21.02	8.16	5.62
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	183.97	27.18	2.25	1.29	2.41	0.80
epidermoid carcinoma cell line:A431	10426-106D3	336.25	9.56	4.56	1.11	0.67	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	342.93	7.70	6.05	1.65	0.88	0.33
epididymis, adult	10197-103E8	280.06	9.42	4.60	1.47	4.81	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	672.03	10.11	18.81	14.73	3.73	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	232.41	8.65	2.75	5.11	1.18	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	155.03	4.72	1.57	2.62	1.18	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	168.89	4.63	1.08	2.46	1.28	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	174.77	6.39	1.90	3.25	1.46	0.45
esophagus, adult, pool1	10015-101C6	265.34	2.97	3.72	0.85	0.85	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	108.45	3.76	5.89	2.63	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	207.65	0.00	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	155.71	0.00	2.10	0.00	4.21	0.00
eye - muscle medial, donor2	10299-104H2	171.14	1.49	1.49	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	170.83	3.44	3.44	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	77.24	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	204.91	2.29	4.07	1.02	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	419.81	35.90	3.33	12.18	3.46	2.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	298.67	6.41	2.61	1.66	1.42	1.19
frontal lobe, adult, pool1	10040-101F4	55.64	0.38	2.06	0.09	0.19	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	197.26	3.30	1.20	1.20	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	686.87	20.66	5.85	13.72	2.10	2.10
gall bladder, adult	10198-103E9	224.29	8.69	2.90	2.66	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	146.56	0.54	3.22	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	134.46	1.12	1.12	0.00	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	212.27	1.90	1.48	0.21	5.70	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	209.86	9.67	0.58	0.00	0.97	0.19
gastric cancer cell line:AZ521	10549-107H9	258.89	26.40	4.92	5.74	0.66	2.13
gastric cancer cell line:GSS	10560-108A2	94.27	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	154.67	1.37	1.83	0.00	2.51	0.00
giant cell carcinoma cell line:LU65	10487-107B1	156.74	4.82	0.80	1.49	0.80	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	504.13	19.31	9.52	5.18	1.68	2.52
glassy cell carcinoma cell line:HOKUG	10688-109F4	272.36	15.71	4.49	2.99	1.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	390.12	8.23	5.49	1.69	1.27	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	442.24	10.11	5.48	1.40	0.70	0.56
glioblastoma cell line:T98G	10485-107A8	212.36	8.72	1.21	1.66	0.88	0.00
glioma cell line:GI-1	10413-106B8	440.49	2.64	4.39	0.00	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	109.34	2.92	2.92	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	160.61	0.98	1.95	0.24	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	82.15	1.37	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	65.02	1.60	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	637.43	20.80	6.72	1.28	2.24	1.28
hIPS +CCl2, biol_rep1	14383-156B9	109.73	6.43	0.00	0.46	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	86.42	5.49	0.46	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	103.05	7.09	0.00	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	56.05	4.31	0.00	1.44	1.44	1.44
hIPS, biol_rep2	14381-156B7	79.56	2.74	0.69	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	43.04	2.21	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	53.73	0.29	0.86	0.00	0.29	0.00
heart - mitral valve, adult	10205-103F7	371.62	3.29	4.78	0.90	3.59	0.30
heart - pulmonic valve, adult	10206-103F8	471.70	3.40	6.54	0.26	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	392.17	0.83	7.49	0.00	3.33	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	192.43	3.67	3.47	0.61	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	268.70	1.28	2.98	0.43	1.70	0.00
heart, adult, pool1	10016-101C7	291.84	3.68	4.37	0.92	1.38	0.00
heart, fetal, pool1	10046-101G1	500.87	4.42	10.47	1.03	1.44	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1649.37	56.77	10.18	38.57	6.17	7.71
hepatoblastoma cell line:HuH-6	10633-108I3	196.21	3.57	4.76	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	171.82	7.29	5.30	2.32	1.33	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	180.00	7.65	4.49	2.67	1.46	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	171.99	5.56	6.16	2.43	0.71	0.81
hepatoma cell line:Li-7	10484-107A7	305.18	3.67	2.45	2.78	1.45	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.74	0.40	0.20	0.00	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	69.08	0.00	0.95	0.00	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	87.35	0.00	1.43	0.20	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	24.40	0.50	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	32.08	0.35	0.70	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	200.80	17.09	4.27	4.27	1.22	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	113.69	9.03	5.50	2.16	0.98	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	117.05	9.39	3.81	2.29	0.51	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	71.05	1.13	2.82	1.13	2.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	83.66	0.77	3.87	0.00	2.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	69.09	3.04	6.07	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	68.32	2.04	2.92	0.29	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	78.42	0.65	3.88	0.22	1.29	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	71.74	0.83	2.09	0.42	1.25	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	136.39	5.68	5.92	5.45	0.71	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	115.23	4.66	5.46	2.73	0.80	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	131.97	3.37	4.04	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	120.49	10.64	2.19	3.29	1.56	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	118.89	8.35	2.95	3.44	2.95	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	162.33	13.96	0.87	2.62	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	97.17	2.29	4.20	1.34	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	93.76	5.67	3.92	1.74	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	120.44	3.00	5.50	1.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	67.82	1.51	5.46	1.13	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	71.39	0.91	0.91	0.00	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	71.42	2.19	4.07	0.63	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	109.09	7.51	5.55	6.70	0.65	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	99.58	6.39	5.23	6.97	1.16	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	101.93	7.77	4.18	4.78	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	120.45	6.84	3.51	0.92	1.48	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	104.70	7.99	5.14	0.86	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	154.75	13.07	3.27	0.82	0.41	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	97.17	2.46	2.82	0.35	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	82.35	2.85	2.53	0.32	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	89.88	3.03	3.03	0.91	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	66.19	1.55	6.21	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	71.07	1.99	1.99	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	66.44	1.80	4.62	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	115.81	7.67	4.86	2.81	1.79	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	80.27	6.82	3.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	116.95	9.75	4.37	5.71	1.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	97.09	3.86	2.90	1.45	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	99.83	7.58	3.12	2.23	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	97.56	9.76	1.95	0.49	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	93.52	2.14	3.06	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	426.17	9.76	6.51	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	110.53	1.99	2.32	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	67.32	1.09	2.19	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	68.76	0.00	2.53	0.36	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.06	0.71	2.49	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	83.54	2.39	3.58	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	143.55	7.04	6.91	2.03	0.81	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	79.74	6.47	4.58	1.62	0.27	0.27
immature langerhans cells, donor1	11904-125F5	128.34	5.81	0.73	0.48	0.48	0.00
immature langerhans cells, donor2	11905-125F6	45.15	1.58	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	47.13	0.28	1.32	0.09	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	117.38	2.93	0.65	0.65	0.98	1.30
kidney, adult, pool1	10017-101C8	231.49	6.21	2.90	1.00	0.60	0.10
kidney, fetal, pool1	10045-101F9	198.48	2.69	5.02	0.78	0.57	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	352.50	2.84	3.55	0.14	0.57	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	147.92	6.64	0.97	0.28	1.24	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	113.95	10.28	1.65	4.04	0.37	2.02
left atrium, adult, donor1	10079-102A7	324.73	2.18	3.81	1.09	2.18	0.54
left ventricle, adult, donor1	10078-102A6	298.84	2.02	2.02	0.51	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	809.89	35.84	10.12	15.32	2.74	7.11
leiomyoma cell line:10964C	10569-108B2	567.25	35.57	10.78	12.93	6.47	5.03
leiomyoma cell line:15242A	10570-108B3	567.94	48.37	7.61	26.63	12.50	12.50
leiomyoma cell line:15425	10571-108B4	801.78	52.45	11.41	20.88	11.41	14.08
leiomyosarcoma cell line:Hs 5.T	10722-110A2	819.07	19.05	6.35	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	364.90	11.50	3.14	1.05	2.09	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	112.98	1.77	1.18	0.71	0.47	0.47
liposarcoma cell line:KMLS-1	10782-110G8	811.35	41.40	9.22	14.06	5.00	5.62
liposarcoma cell line:SW 872	10726-110A6	238.68	9.75	1.10	5.12	1.46	1.58
liver, adult, pool1	10018-101C9	314.07	12.80	4.70	1.30	1.46	0.32
liver, fetal, pool1	10086-102B5	149.57	3.76	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	117.97	0.73	3.65	0.44	0.58	0.00
locus coeruleus, adult, donor10252	10165-103B3	105.19	0.74	3.51	0.55	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	49.09	0.85	1.97	0.00	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	85.81	0.42	1.26	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	470.13	81.93	8.30	35.01	1.11	10.93
lung adenocarcinoma cell line:PC-14	10408-106B3	233.02	12.41	2.76	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	207.48	4.09	1.98	0.13	1.45	0.00
lung, adult, pool1	10019-101D1	324.85	4.84	5.08	0.83	1.06	0.47
lung, fetal, donor1	10068-101I5	509.74	2.28	1.71	0.57	3.42	0.29
lung, right lower lobe, adult, donor1	10075-102A3	271.72	7.33	2.75	0.46	0.92	0.00
lymph node, adult, donor1	10077-102A5	131.59	1.89	0.95	0.00	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	61.15	0.66	0.22	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	58.41	1.06	1.21	0.30	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	136.77	7.65	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	880.43	39.96	11.10	4.88	0.89	4.00
mature adipocyte, donor2	12232-129F9	970.82	20.55	13.49	0.83	1.66	0.42
mature adipocyte, donor3	12233-129G1	886.62	25.60	12.33	1.90	0.71	1.66
mature adipocyte, donor4	12234-129G2	897.83	35.01	12.37	3.16	1.05	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	97.45	2.86	3.10	0.48	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	76.14	0.18	2.39	0.37	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	33.99	0.64	0.32	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	85.30	0.00	0.43	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	58.39	0.17	1.01	0.34	1.01	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	79.80	0.21	1.70	0.21	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	29.79	0.00	0.00	0.00	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	106.43	1.30	0.65	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	128.18	0.93	2.63	0.15	0.93	0.00
medulla oblongata, adult, pool1	10038-101F2	107.99	0.73	3.67	0.33	0.73	0.08
medulla oblongata, newborn, donor10223	10361-105F1	59.72	0.00	1.74	0.35	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	126.20	1.33	2.21	0.22	1.11	0.00
medulloblastoma cell line:ONS-76	10759-110E3	229.02	5.75	1.96	2.93	1.22	0.61
melanoma cell line:COLO 679	10514-107E1	101.34	2.73	0.57	0.29	0.14	0.14
melanoma cell line:G-361	10465-106H6	131.93	2.71	1.63	0.27	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	312.42	9.23	4.16	8.68	3.08	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	216.76	0.00	5.29	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	76.73	0.26	2.85	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	881.48	40.05	7.36	15.04	4.45	4.60
mesenchymal precursor cell - adipose, donor2	11748-123G2	812.20	12.36	3.27	3.64	2.54	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	604.18	11.59	2.90	3.73	5.80	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	798.46	12.08	5.34	2.39	2.25	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	560.95	6.93	3.08	0.77	1.73	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	524.72	6.25	7.63	3.47	4.16	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	798.10	24.03	3.43	4.12	4.12	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	653.98	14.03	5.64	1.84	3.45	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	1009.24	45.10	7.43	12.73	5.31	4.38
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1095.85	29.30	8.78	7.02	5.13	4.19
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	1249.07	46.95	8.68	18.49	3.98	7.11
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	842.82	19.43	11.86	14.16	7.25	2.96
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	1194.98	54.10	9.82	13.28	4.15	4.84
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	673.73	48.87	6.98	10.47	9.43	2.44
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1487.54	50.63	11.43	22.05	7.96	7.35
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	877.79	39.90	12.94	20.49	10.42	8.63
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	1220.09	43.35	9.21	10.45	5.17	2.38
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	939.33	59.28	23.94	36.93	12.08	15.28
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1467.19	53.70	7.97	20.14	9.65	6.71
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1433.56	52.75	10.16	16.29	5.98	6.87
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	798.02	26.61	5.86	4.99	3.94	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1005.44	22.83	13.25	7.73	5.89	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1094.27	62.95	17.46	28.90	10.30	15.74
mesenchymal stem cell line:Hu5/E18	10568-108B1	511.95	8.84	6.32	2.53	10.10	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	564.90	7.76	4.11	2.74	1.83	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	556.08	11.25	5.12	2.56	5.63	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	609.63	12.30	5.76	3.40	4.45	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	531.45	13.56	7.09	2.16	9.86	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	546.49	15.06	5.18	3.29	6.83	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	557.10	11.17	5.08	2.71	3.05	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	528.55	11.00	7.07	1.18	6.68	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	486.09	9.27	5.56	2.78	6.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	869.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	717.87	17.59	8.65	3.75	7.50	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	591.44	14.50	5.35	3.57	3.79	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	559.54	13.94	5.05	2.16	6.97	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	816.19	16.87	11.73	5.87	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	508.52	12.75	6.38	2.35	5.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	512.54	17.19	6.14	2.46	3.68	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	524.06	15.89	6.44	3.44	4.73	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	494.93	19.14	8.20	8.20	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	655.95	5.16	0.00	5.16	20.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	636.26	12.99	9.09	3.57	6.82	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	557.26	18.91	1.45	2.91	2.91	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	597.58	15.99	4.80	2.67	3.73	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	559.36	16.36	7.36	6.54	9.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	555.09	12.05	8.16	1.55	10.11	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	430.24	16.79	8.39	2.10	10.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	549.39	6.95	4.97	0.99	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	619.74	19.07	9.53	4.77	14.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	582.88	11.86	5.93	3.56	6.52	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	672.59	18.28	9.75	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	378.73	27.05	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	634.02	17.10	6.97	3.17	6.97	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	702.91	18.28	4.83	5.17	11.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	640.46	17.19	8.60	8.60	4.30	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	411.15	11.98	3.99	3.99	7.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	650.89	13.78	3.44	3.44	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	472.67	8.96	2.85	1.22	8.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	527.51	7.94	2.38	2.38	14.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	259.98	3.54	2.36	0.59	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	295.50	1.56	2.49	0.31	2.81	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	279.36	1.34	1.34	0.00	10.69	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	232.99	2.37	1.18	0.00	5.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	256.80	2.57	0.00	0.00	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	256.08	1.38	0.00	0.00	6.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	232.56	5.44	2.47	0.49	4.45	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	172.71	6.73	0.00	0.00	5.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	228.98	3.18	0.64	0.64	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	150.31	4.43	1.61	0.40	3.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	159.18	8.72	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	232.44	9.10	2.43	0.61	3.03	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	234.99	0.00	4.52	0.00	18.08	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	226.51	11.53	1.65	1.65	4.12	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	220.65	3.37	1.59	0.20	0.99	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	215.79	2.92	1.62	0.00	2.27	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	225.12	1.02	2.04	0.00	9.17	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	715.69	29.40	6.19	8.51	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	466.10	14.41	5.67	3.78	1.42	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	366.97	5.56	2.78	1.85	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	418.81	12.82	0.00	12.82	29.92	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	606.64	17.78	3.49	7.91	6.37	1.23
mesothelioma cell line:Mero-25	10850-111F4	151.15	6.58	2.50	2.27	1.59	0.68
mesothelioma cell line:Mero-41	10851-111F5	377.71	13.45	3.42	2.20	7.33	1.22
mesothelioma cell line:Mero-48a	10852-111F6	116.03	7.31	0.89	0.66	1.33	0.44
mesothelioma cell line:Mero-82	10853-111F7	210.24	3.68	1.58	0.26	6.57	0.00
mesothelioma cell line:Mero-83	10854-111F8	253.29	9.87	2.89	1.87	3.06	0.51
mesothelioma cell line:Mero-84	10855-111F9	140.04	5.31	1.52	1.01	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	181.58	5.59	1.24	1.45	1.24	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	252.45	15.41	4.14	7.79	3.48	1.16
mesothelioma cell line:NCI-H226	10846-111E9	135.38	4.16	1.45	2.35	2.71	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	651.00	24.43	7.00	2.90	8.20	0.85
mesothelioma cell line:NCI-H28	10845-111E8	200.26	14.76	2.54	2.04	4.58	0.51
mesothelioma cell line:No36	10857-111G2	120.04	3.91	2.61	0.00	1.63	0.00
mesothelioma cell line:ONE58	10858-111G3	146.86	14.09	1.08	1.63	4.61	1.35
migratory langerhans cells, donor1	11901-125F2	88.28	0.58	1.15	0.19	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	109.17	0.12	0.49	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	100.33	0.54	1.62	0.00	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	255.31	1.63	0.98	0.33	6.86	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	361.77	5.09	1.06	1.27	4.03	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	652.60	57.13	9.44	16.13	1.15	6.91
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.95	0.38	0.19	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	131.76	5.36	1.11	0.74	0.37	0.74
myeloma cell line:PCM6	10474-106I6	67.80	0.40	0.20	0.00	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	797.97	55.80	11.16	14.71	2.54	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	241.84	2.16	1.77	0.00	1.96	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	340.63	1.23	4.35	1.23	1.23	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	327.62	2.57	3.97	1.10	0.74	0.22
nasal epithelial cells, donor2	12227-129F4	379.77	15.46	4.97	6.07	2.21	1.66
neuroblastoma cell line:CHP-134	10508-107D4	205.44	2.53	6.21	0.23	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	244.89	0.75	7.67	0.00	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	107.97	1.27	1.69	0.21	0.63	0.00
neuroblastoma cell line:NH-12	10555-107I6	157.65	1.30	2.42	0.00	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	161.79	0.71	1.90	0.24	1.66	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	118.94	1.11	1.58	0.00	1.43	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	53.33	0.40	0.40	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	47.68	1.27	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	906.03	21.03	7.98	6.65	2.93	4.26
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	229.16	0.51	2.20	0.17	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	180.11	1.60	5.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	493.41	9.94	1.92	1.92	4.17	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	417.27	10.51	3.94	2.89	5.78	2.10
nucleus accumbens, adult, pool1	10037-101F1	67.59	0.37	2.62	0.00	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	51.51	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	110.83	0.27	2.15	0.00	1.34	0.00
occipital cortex, newborn, donor10223	10355-105E4	37.49	0.36	0.36	0.00	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	56.68	0.00	1.05	0.52	1.31	0.26
occipital lobe, fetal, donor1	10073-102A1	71.66	0.00	2.15	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	27.91	0.16	0.79	0.00	0.16	0.00
olfactory region, adult	10195-103E6	53.49	0.38	1.72	0.00	0.57	0.00
optic nerve, donor1	10277-104E7	234.12	4.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	327.03	14.24	3.65	3.87	1.14	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	182.86	5.77	2.75	1.10	0.14	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	303.77	9.99	2.03	4.74	2.71	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	114.24	1.73	0.69	0.69	0.58	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	549.13	19.40	3.82	1.76	1.47	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	481.18	31.77	9.34	2.80	0.00	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	127.24	0.42	2.54	0.00	0.21	0.00
ovary, adult, pool1	10020-101D2	219.34	1.48	5.77	0.09	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	553.81	11.18	5.32	6.60	2.38	1.28
pancreas, adult, donor1	10049-101G4	167.43	2.82	0.94	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	120.20	1.40	0.56	0.84	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	299.65	11.41	2.04	3.75	5.11	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	819.30	70.37	12.75	27.82	0.83	8.61
paracentral gyrus, adult, pool1	10035-101E8	58.76	1.01	1.19	0.09	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	30.09	2.20	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	66.77	0.00	0.94	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	72.11	0.57	1.71	0.00	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	57.81	0.44	2.38	0.26	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	108.62	0.00	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	38.88	0.00	1.12	0.37	0.00	0.00
parotid gland, adult	10199-103F1	125.18	3.08	0.62	0.00	0.62	0.62
penis, adult	10200-103F2	311.53	3.22	3.22	0.54	10.21	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	24.36	0.00	0.19	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	220.73	8.60	0.87	2.91	1.60	0.73
pineal gland - adult, donor10196	10179-103C8	78.05	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	90.61	0.59	2.37	0.59	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	52.67	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	259.02	0.00	6.07	0.00	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	342.41	1.56	7.82	0.00	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	153.22	1.70	2.55	0.00	2.55	0.00
placenta, adult, pool1	10021-101D3	361.85	10.43	4.41	4.19	0.97	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	11.39	0.00	0.26	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	714.23	16.03	5.14	5.45	2.65	0.93
pons, adult, pool1	10033-101E6	89.68	0.60	3.61	0.17	0.26	0.00
postcentral gyrus, adult, pool1	10032-101E5	37.83	0.26	1.22	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	654.02	114.64	17.92	19.96	5.39	12.24
prostate cancer cell line:PC-3	10439-106E7	607.12	26.32	8.35	2.72	3.45	0.91
prostate, adult, pool1	10022-101D4	267.18	1.00	4.44	0.18	0.36	0.09
putamen, adult, donor10196	10176-103C5	55.24	0.24	1.65	0.00	0.47	0.00
putamen, adult, donor10252	10152-102I8	66.66	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	5.46	0.00	3.28	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	40.35	0.24	1.69	0.48	0.48	0.00
putamen, newborn, donor10223	10365-105F5	59.22	0.00	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	196.09	2.91	3.20	0.29	0.29	0.00
rectum, fetal, donor1	10067-101I4	459.03	15.30	1.39	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	456.22	22.47	8.27	2.54	2.76	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	235.69	7.46	1.66	0.83	1.24	0.00
retina, adult, pool1	10030-101E3	115.20	1.09	2.29	0.10	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	27.28	0.26	1.56	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	121.60	16.84	1.11	5.29	0.25	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	126.26	0.84	2.53	0.00	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	598.70	12.88	12.88	0.76	1.52	2.27
salivary acinar cells, donor1	11771-123I7	472.62	19.58	7.45	7.61	3.72	4.21
salivary acinar cells, donor2	11772-123I8	455.19	9.64	4.41	1.65	4.54	1.24
salivary acinar cells, donor3	11773-123I9	568.70	7.94	2.65	1.99	1.99	0.66
salivary gland, adult, pool1	10093-102C3	118.97	0.00	0.00	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	230.34	9.86	4.89	3.79	1.18	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	284.36	9.87	3.88	3.88	0.47	1.29
seminal vesicle, adult	10201-103F3	385.16	6.35	5.82	1.06	15.87	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	99.36	8.26	0.24	0.97	0.73	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	245.84	4.28	2.01	0.75	2.52	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	514.81	15.05	6.02	6.02	8.03	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	221.49	10.88	5.10	2.28	3.09	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	164.91	4.31	3.43	0.33	0.44	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	63.61	9.03	0.39	1.55	0.39	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	271.68	1.42	9.93	0.00	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	187.70	1.44	4.32	0.48	0.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	186.93	1.01	2.01	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	169.63	0.00	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	426.08	3.79	3.16	0.63	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	136.08	3.00	1.67	0.33	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	144.99	1.58	1.89	0.00	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	256.16	2.89	9.25	0.19	1.54	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	125.27	2.97	2.14	0.33	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	54.85	0.00	1.45	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	164.31	0.65	1.74	0.22	1.96	0.22
small intestine, adult, pool1	10024-101D6	246.77	12.54	4.06	1.19	0.72	0.72
small intestine, fetal, donor1	10064-101I1	260.19	3.19	4.18	0.74	2.21	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	88.73	2.56	0.51	0.51	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	462.63	1.81	4.91	0.26	2.84	0.26
somatostatinoma cell line:QGP-1	10781-110G7	153.04	13.94	0.80	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	163.11	0.46	3.67	0.23	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	168.35	0.00	2.37	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	110.00	0.00	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	123.80	0.61	3.66	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	135.47	0.46	3.67	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	1248.60	31.66	8.81	7.02	6.42	2.54
spleen, adult, pool1	10025-101D7	278.86	4.52	2.42	1.54	0.99	0.33
spleen, fetal, pool1	10044-101F8	185.53	2.22	3.58	0.87	0.16	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	81.98	0.21	2.07	0.00	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	103.86	3.99	0.76	0.76	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	154.81	1.75	2.10	0.35	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	143.47	8.21	1.95	8.60	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	134.73	2.14	1.80	0.68	0.68	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	103.78	2.54	0.85	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	426.88	19.46	1.69	2.96	0.85	2.12
stomach, fetal, donor1	10062-101H8	617.29	40.58	1.07	4.27	1.07	1.07
submaxillary gland, adult	10202-103F4	147.55	1.71	3.42	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	651.29	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	139.37	0.42	1.87	0.21	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	50.17	0.52	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	78.43	0.00	1.41	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	205.65	6.42	10.32	0.92	2.06	0.00
temporal lobe, adult, pool1	10031-101E4	25.86	0.34	1.53	0.08	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	0.71	1.42	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	48.35	0.00	1.32	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	886.02	12.92	9.77	1.40	16.41	0.70
tenocyte, donor2	11765-123I1	492.91	7.25	4.20	0.00	8.77	0.00
tenocyte, donor3	11768-123I4	677.58	13.71	4.08	4.45	14.09	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	129.17	7.31	2.55	1.53	0.85	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	169.10	3.39	1.70	0.46	2.47	0.46
teratocarcinoma cell line:PA-1	10807-111A6	178.38	27.28	3.41	15.50	2.17	2.17
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	191.44	3.68	2.67	1.02	1.14	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	79.04	2.65	3.40	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	297.74	6.98	2.18	2.62	0.33	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	106.50	6.19	0.00	1.95	1.63	0.98
testis, adult, pool1	10026-101D8	210.88	2.25	5.80	0.21	0.86	0.11
testis, adult, pool2	10096-102C6	117.73	1.35	4.96	0.00	4.51	0.00
thalamus - adult, donor10196	10168-103B6	93.84	2.21	2.21	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	120.34	0.31	2.97	0.16	0.78	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	50.81	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	37.22	0.66	0.16	0.16	0.33	0.00
thalamus, newborn, donor10223	10366-105F6	33.94	0.00	0.58	0.00	0.00	0.00
throat, adult	10209-103G2	130.08	0.25	2.25	0.25	1.50	0.00
throat, fetal, donor1	10061-101H7	317.20	3.96	1.83	0.91	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	71.54	1.19	1.39	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	65.71	0.99	0.99	0.00	0.00	0.00
thymus, fetal, pool1	10043-101F7	119.49	1.04	1.56	0.10	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	314.05	4.12	3.19	1.33	1.86	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	336.65	6.71	4.05	1.12	2.79	0.42
thyroid, adult, pool1	10028-101E1	204.54	1.40	3.45	0.09	0.47	0.00
thyroid, fetal, donor1	10060-101H6	278.96	6.06	5.27	0.79	3.16	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	298.72	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	117.92	0.70	1.40	0.00	2.09	0.00
tongue, fetal, donor1	10059-101H5	348.77	1.97	2.76	0.39	2.76	0.00
tonsil, adult, pool1	10047-101G2	114.80	2.10	1.20	0.20	0.50	0.20
trachea, adult, pool1	10029-101E2	211.53	4.01	2.70	1.39	0.49	0.33
trachea, fetal, donor1	10058-101H4	315.83	1.54	4.62	0.77	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	587.74	26.22	5.67	5.31	7.44	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	244.17	6.28	4.15	2.53	0.51	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	264.80	4.54	4.23	0.78	1.72	0.31
tridermal teratoma cell line:HGRT	10694-109G1	1149.13	45.66	13.32	15.22	0.00	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	609.14	78.98	3.39	45.54	4.74	24.89
umbilical cord, fetal, donor1	10057-101H3	369.31	4.17	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	452.16	1.88	2.56	0.34	0.85	0.00
uterus, fetal, donor1	10055-101H1	561.07	3.58	7.68	2.05	3.07	0.00
vagina, adult	10204-103F6	204.85	0.00	3.88	0.00	0.65	0.00
vein, adult	10191-103E2	165.71	2.85	2.41	1.32	1.32	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.43	0.00	0.27	0.00	0.00	0.00